ao link

You are viewing 1 of your 3 articles before login/registration is required

References

  1. M Fogel-Levin et al., “Advanced retinal imaging and applications for clinical practice: A consensus review,” Survey of Ophthalmology, 67 1373–1390 (2022).
  2. N Choudhry et al., “Classification and guidelines for widefield imaging: recommendations from the international widefield imaging study group,” Ophthalmol. Retina, 3, 843–849 (2019).
  3. PE Stanga, AC Bird “Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results,” Int. Ophthalmol., 23, 191-197 (2001).
  4. PE Stanga et al., “Swept-source optical coherence tomography angio™ (Topcon Corp, Japan): technology review,” Dev. Ophthalmol., 56, 13-17 (2016).
  5. MM Muqit et al., “Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy, Acta. Ophthalmol., 91, 251-258 (2013).
  6. PE Stanga et al., “Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results,” Int. Ophthalmol. 23, 321-5 (2001)
  7. D Huang, “Optical coherence tomography,” Science, 254, 1178–1181 (1991)
  8. PE Stanga et al., “In vivo imaging of cortical vitreous using 1050-nm swept-source deep range imaging optical coherence tomography,” Am. J Ophthalmol. 157, 397-404 (2014).
  9. PE Stanga et al., “Navigated single-capture 3D and cross-sectional wide-field OCT of the mid and peripheral retina and vitreoretinal interface,” Eur. J Ophthalmol., 32, 1642–1651 (2022).
  10. N Quinn et al., “The clinical relevance of visualizing the peripheral retina,” Prog. Retin. Eye Res., 68, 83–109 (2019).
  11. BA Holden et al., “Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050,” Ophthalmology, 123, 1036–1042 (2016).
  12. JH Nguyen et al., “Vitreous structure and visual function in myopic vitreopathy causing vision-degrading myodesopsia,” Am. J Ophthalmol., 224, 246–253 (2021).
  13. PE Stanga et al. (in press), “New terminology and methodology for the assessment of the vitreous, its floaters and opacities, and their effect on vision: standardized and kinetic anatomical & functional testing of VFO (vitreous floaters and opacities) (SK VFO Test), Ophthalmic Surg. Lasers Imaging Retina (2023).
  14. PE Stanga, D Reinstein, “Managing vision degrading myodesopsia (VDM): assessment of the vitreoretinal interface (VRI) and vitreous opacity (VO), intra-laser videos and first year results using YAG laser vitreolysis (YLV),” Poster presentation, Jules Gonin Meeting 2020.
  15. DD Dysager et al., “Efficacy and safety of pars plana vitrectomy for primary symptomatic floaters: a systematic review with meta-analyses,” Ophthal. Ther., 11, 2225–2242 (2022).

Professor Paulo E. Stanga

The New Optometrist Newsletter

All Content


Journal of a Rural Australian Eye Doctor

Journal of a Rural Australian Eye Doctor


“Integration” in Ghanaian Ophthalmology

“Integration” in Ghanaian Ophthalmology


The Blue-Eyed Monster

The Blue-Eyed Monster


In Other News

In Other News

Sign up to The New Optometrist Updates

Sign up here to receive our latest interviews, features, reports and more.

All Content

Journal of a Rural Australian Eye Doctor

Journal of a Rural Australian Eye Doctor

“Integration” in Ghanaian Ophthalmology

“Integration” in Ghanaian Ophthalmology

The Blue-Eyed Monster

The Blue-Eyed Monster

In Other News

In Other News

Sign up to The New Optometrist Updates

© 2023 Texere Publishing Inc. All rights reserved. Reproduction in the whole or in parts is prohibited. 
Follow us on Twitter
Follow us on Facebook
Follow us on LinkedIn
Texere Publishing